Dr. Reddy's Laboratories announced today that it has launched Levetiracetram in Sodium Chloride Injection, 500 mg/100 ml (5 mg/ml), 1,000 mg/100 ml (10 mg/ml), and 1,500 mg/100 ml (15 mg/ml) single-dose infusion bags, a therapeutic equivalent generic version of HQ Specialty Pharma Corporation's Levetiracetam in Sodium Chloride Injection , approved by the U.S. Food and Drug Administration (USFDA).

The Levetiracetam in Sodium Chloride Injection brand and generic had U.S. sales of approximately USD 37 million MAT for the most recent twelve months ending in April 2018 according to IMS Health.

Dr. Reddy's levetiracetam in Sodium Chloride Injection is available in strengths of 500 mg/100 ml (5 mg/ml), 1,000 mg/100 ml (10 mg/ml), and 1,500 mg/100 ml (15 mg/ml) single-dose infusion bags.

Shares of the company gained Rs 34.7, or 1.46%, to trade at Rs 2,414.95. The total volume of shares traded was 92,280 at the BSE (12.04 p.m., Tuesday).